RecruitingPhase 3NCT06763328
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
Sponsor: City of Hope Medical Center
Duarte, CA · La Jolla, CA · Riverside, CA
Breast Cancer clinical trials in La Jolla, CA
14 recruiting breast cancer studies with a site in La Jolla, CA.
RecruitingPhase 1NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor: Eli Lilly and Company
Duarte, CA · La Jolla, CA · Los Angeles, CA · +20 more sites
RecruitingPhase 3NCT07174336
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Sponsor: Eli Lilly and Company
Clovis, CA · Duarte, CA · Emeryville, CA · +126 more sites
RecruitingPhase not listedNCT00477100
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Sponsor: M.D. Anderson Cancer Center
La Jolla, CA · +9 more sites
RecruitingPhase 3NCT06790693
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Sponsor: Hoffmann-La Roche
Burbank, CA · Irvine, CA · La Jolla, CA · +59 more sites
RecruitingPhase 3NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Sponsor: Stemline Therapeutics, Inc.
Bakersfield, CA · Berkeley, CA · Beverly Hills, CA · +173 more sites
RecruitingPhase not listedNCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Sponsor: Guardant Health, Inc.
La Jolla, CA · Newport Beach, CA · Redwood City, CA · +30 more sites
RecruitingPhase 1NCT07216105
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Sponsor: Fate Therapeutics
La Jolla, CA · Los Angeles, CA · +3 more sites
RecruitingPhase 3NCT05232916
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Sponsor: Greenwich LifeSciences, Inc.
Duarte, CA · Fullerton, CA · Irvine, CA · +48 more sites
RecruitingPhase 1NCT06545942
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Sponsor: MOMA Therapeutics
La Jolla, CA · San Francisco, CA · +10 more sites
RecruitingPhase not listedNCT03448926
The PREDICT Registry:
Sponsor: PreludeDx
La Jolla, CA · San Mateo, CA · +28 more sites
RecruitingPhase 1 / Phase 2NCT06956690
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
Sponsor: Hummingbird Bioscience
La Jolla, CA · +4 more sites
RecruitingPhase 1 / Phase 2NCT06682793
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Sponsor: A2 Biotherapeutics Inc.
La Jolla, CA · Los Angeles, CA · +8 more sites
RecruitingPhase 1NCT04282044
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Sponsor: BioEclipse Therapeutics
La Jolla, CA · Stanford, CA · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.